Clinical Trial Update: Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin [Phase 3]

View source ↗

Summary

Phase 3 trial in squamous non-small cell lung cancer comparing ipilimumab with paclitaxel and carboplatin to placebo with paclitaxel and carboplatin has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• ipilimumab (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lung Cancer (NSCLC) | Phase 3 | Status: COMPLETED | Results posted: 2019-08-28